IL146632A0 - Pharmaceutical tablets - Google Patents
Pharmaceutical tabletsInfo
- Publication number
- IL146632A0 IL146632A0 IL14663200A IL14663200A IL146632A0 IL 146632 A0 IL146632 A0 IL 146632A0 IL 14663200 A IL14663200 A IL 14663200A IL 14663200 A IL14663200 A IL 14663200A IL 146632 A0 IL146632 A0 IL 146632A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical tablets
- tablets
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14198799P | 1999-07-01 | 1999-07-01 | |
| PCT/US2000/017569 WO2001001991A1 (fr) | 1999-07-01 | 2000-06-27 | Comprimes pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146632A0 true IL146632A0 (en) | 2002-07-25 |
Family
ID=22498098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14663200A IL146632A0 (en) | 1999-07-01 | 2000-06-27 | Pharmaceutical tablets |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20010036475A1 (fr) |
| EP (1) | EP1196175A1 (fr) |
| JP (1) | JP2003503460A (fr) |
| KR (1) | KR20020015063A (fr) |
| AR (1) | AR024462A1 (fr) |
| AU (1) | AU6055400A (fr) |
| CA (1) | CA2378521A1 (fr) |
| HK (1) | HK1041816A1 (fr) |
| IL (1) | IL146632A0 (fr) |
| NZ (1) | NZ515614A (fr) |
| WO (1) | WO2001001991A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1465606A4 (fr) | 2001-12-24 | 2009-04-22 | Teva Pharma | Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique |
| US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
| NZ556278A (en) | 2002-05-10 | 2009-06-26 | Hoffmann La Roche | Bisphosphonic acid for the treatment and prevention of osteoperosis |
| ES2530791T3 (es) | 2002-12-20 | 2015-03-05 | Hoffmann La Roche | Formulación de ibandronato de altas dosis |
| US20050096365A1 (en) * | 2003-11-03 | 2005-05-05 | David Fikstad | Pharmaceutical compositions with synchronized solubilizer release |
| US20080286359A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US20080287400A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US7645459B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US7645460B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
| US20080139514A1 (en) * | 2006-11-29 | 2008-06-12 | Subhash Pandurang Gore | Diphosphonic acid pharmaceutical compositions |
| KR20100014090A (ko) * | 2008-08-01 | 2010-02-10 | 동화약품주식회사 | 벤즈아미딘 유도체 또는 이의 염, 및 비스포스포네이트를 포함하는 골다공증의 예방 또는 치료용 약학 조성물 |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| WO2016033556A1 (fr) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide |
| WO2016033549A2 (fr) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| US9711456B2 (en) | 2015-12-19 | 2017-07-18 | International Business Machines Corporation | Composite manganese nitride/low-K dielectric cap |
| EP3544614B1 (fr) | 2016-11-28 | 2025-12-31 | Lipocine Inc. | Traitement oral à base d'undécanoate de testostérone |
| CA3107214A1 (fr) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Maladie du foie |
| WO2020156959A1 (fr) * | 2019-01-28 | 2020-08-06 | Katjes Fassin Gmbh. + Co. Kommanditgesellschaft | Compositions contenant de la cire de pomme |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1036368A (en) | 1963-10-31 | 1966-07-20 | Nat Dairy Prod Corp | Method for the manufacture of lactose-containing tablets |
| DE2534391C2 (de) | 1975-08-01 | 1983-01-13 | Henkel KGaA, 4000 Düsseldorf | 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren |
| DE2745083C2 (de) | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung |
| IT1201087B (it) | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| JPH07100665B2 (ja) | 1987-12-23 | 1995-11-01 | 信越化学工業株式会社 | 被覆薬剤の製造方法 |
| CA1339805C (fr) | 1988-01-20 | 1998-04-07 | Yasuo Isomura | Acide (cycloalkylamino) methylenebis phosphonique et medicaments le contenant comme ingredients actif |
| US5047246A (en) | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
| JP2525478B2 (ja) | 1989-03-01 | 1996-08-21 | 帝人株式会社 | 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤 |
| US5070108A (en) | 1990-10-12 | 1991-12-03 | Trustees Of The University Of Pennsylvania | Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal |
| US5358941A (en) | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
| JP3411690B2 (ja) * | 1994-09-21 | 2003-06-03 | 帝人株式会社 | 局所投与用アレンドロン酸ナトリウム製剤 |
| DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| EP0935523B1 (fr) * | 1996-10-28 | 2004-09-29 | Inc. General Mills | Inclusion et encapsulation de particules a liberation controlee |
| ES2226128T3 (es) | 1997-06-11 | 2005-03-16 | THE PROCTER & GAMBLE COMPANY | Comprimido revestido con una pelicula para una seguridad del tracto gastrointestinal superior mejorada. |
| KR100336090B1 (ko) * | 1998-06-27 | 2002-05-27 | 윤승원 | 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제 |
-
2000
- 2000-06-23 AR ARP000103154A patent/AR024462A1/es not_active Application Discontinuation
- 2000-06-27 CA CA002378521A patent/CA2378521A1/fr not_active Abandoned
- 2000-06-27 JP JP2001507483A patent/JP2003503460A/ja not_active Withdrawn
- 2000-06-27 IL IL14663200A patent/IL146632A0/xx unknown
- 2000-06-27 HK HK02103495.2A patent/HK1041816A1/zh unknown
- 2000-06-27 AU AU60554/00A patent/AU6055400A/en not_active Abandoned
- 2000-06-27 WO PCT/US2000/017569 patent/WO2001001991A1/fr not_active Ceased
- 2000-06-27 EP EP00946859A patent/EP1196175A1/fr not_active Withdrawn
- 2000-06-27 NZ NZ515614A patent/NZ515614A/xx not_active Application Discontinuation
- 2000-06-27 KR KR1020017016729A patent/KR20020015063A/ko not_active Withdrawn
-
2001
- 2001-06-14 US US09/881,285 patent/US20010036475A1/en not_active Abandoned
-
2002
- 2002-03-15 US US10/099,672 patent/US6623755B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001001991A1 (fr) | 2001-01-11 |
| CA2378521A1 (fr) | 2001-01-11 |
| KR20020015063A (ko) | 2002-02-27 |
| HK1041816A1 (zh) | 2002-07-26 |
| JP2003503460A (ja) | 2003-01-28 |
| AU6055400A (en) | 2001-01-22 |
| AR024462A1 (es) | 2002-10-02 |
| NZ515614A (en) | 2004-01-30 |
| US20010036475A1 (en) | 2001-11-01 |
| EP1196175A1 (fr) | 2002-04-17 |
| US6623755B2 (en) | 2003-09-23 |
| US20020187186A1 (en) | 2002-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL146632A0 (en) | Pharmaceutical tablets | |
| PL351686A1 (en) | Novel pharmaceutical | |
| HUP0203585A3 (en) | Pharmaceutical combinations | |
| AU141186S (en) | Tablet | |
| IL145632A0 (en) | Pharmaceutical compounds | |
| AU145547S (en) | A tablet for example a pharmaceutical tablet | |
| EG23937A (en) | Novel pharmaceutical | |
| GB9916434D0 (en) | Pharmaceutical compounds | |
| GB9914255D0 (en) | Pharmaceutical compounds | |
| PL351135A1 (en) | Novel pharmaceutical | |
| EG23946A (en) | Novel pharmaceutical | |
| IL146341A0 (en) | Pharmaceutical complex | |
| GB9903784D0 (en) | Pharmaceutical compounds | |
| AU145546S (en) | A tablet for example a pharmaceutical tablet | |
| GB9909154D0 (en) | Pharmaceutical formulation | |
| GB2373499B (en) | Pharmaceutical compounds | |
| GB9929498D0 (en) | Tablet package | |
| GB9923933D0 (en) | Novel pharmaceutical | |
| CA88762S (en) | Pharmaceutical tablet | |
| GB9930338D0 (en) | Pharmaceutical device | |
| GB9923934D0 (en) | Novel pharmaceutical | |
| CA84666S (en) | Pharmaceutical tablet | |
| CA83558S (en) | Pharmaceutical tablet | |
| GB9926434D0 (en) | Pharmaceutical | |
| GB9926437D0 (en) | Pharmaceutical |